Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina.: A multicentre study

被引:98
作者
Fainboim, H
González, J
Fassio, E
Martínez, A
Otegui, L
Eposto, M
Cahn, P
Marino, R
Landeira, G
Suaya, G
Gancedo, E
Castro, R
Brajterman, L
Laplumé, H
机构
[1] Professor Alejandro Posadas Hosp, Gastroenterol Serv, RA-1704 Ramos Mejia, Argentina
[2] Dr Francisco Muniz Hosp, Buenos Aires, DF, Argentina
[3] Natl Inst Microbiol Dr Carlos Malbran, Buenos Aires, DF, Argentina
[4] Dr Juan Fernandez Hosp, Buenos Aires, DF, Argentina
关键词
HIV infection; prevalence; viral hepatitis;
D O I
10.1046/j.1365-2893.1999.t01-1-6120135.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The objectives of this study were to investigate the prevalence of infections with hepatotrophic viruses in an anti-human immunodeficiency virus (HIV)-positive population from Buenos Aires and to compare it among the main risk groups for HIV infection. Four hundred and eighty-four consecutive patients attending the HIV outpatients clinic were studied: 359 men and 125 women, median age 29 years (range 16-67 years); 35.5% had presented acquired immune deficiency syndrome (AIDS)-defining conditions, Two hundred and thirty-four patients were intravenous drug users (IVDU), 99 had homosexual and 142 heterosexual preference, seven had received blood transfusions and two had no risk factors, Hepatitis B surface antigen (HBsAg), and antibodies to hepatitis B core antigen (HBcAb) and to hepatitis C virus (anti-HCV) were investigated in all patients: antibodies to HBsAg (HBsAb) and IgG antibodies to hepatitis D virus (anti-HDV) in all HBcAb-positive patients; hepatitis B e antigen and antibodies to HBeAg (HBeAg) in all HBsAg-positive patients; IgG antibodies to hepatitis A virus (anti-HAV) in the first 307 patients; and IgG antibodies to hepatitis E virus (anti-HEV) in the first 91 patients, As control groups, contemporary voluntary blood donors were studied for prevalence of HAV, HBV, HCV and HEV, The percentages of HBcAb, HBsAg, anti-HCV and anti-HEV (58.5, 14.5, 58.5 and 6.6%, respectively) were significantly higher in anti HIV-positive patients than in control groups (3.2, 0.5, 1.0 and 1.8%, respectively) (P = 0.000), The prevalence of HBcAb was significantly higher in IVDU (72.6%) than in heterosexuals (33.8%) (P = 0.0001) and in homosexuals (59.6%) (P = 0.0189). The percentage of HBsAg was significantly higher in IVDU (19.2%) than in heterosexuals (6.3%) (P = 0.0004). Anti-HCV was significantly higher in IVDU (92.3%) than in homosexuals (14.1%) and in heterosexuals (33.1%) (P = 0.000 in both cases), The prevalence of anti-HDV was relatively low (1.9%), There was no difference in the percentage of anti-HIV between HIV-positive and negative subjects. In conclusion, there is a high prevalence of HBV and HCV infections in HIV-positive patients from our area. Drug use is the main route of transmission, but prevalence of HCV in patients with, probably, sexually acquired HIV infection is also higher than in the control group. The increased prevalence of HEV infection in HIV-positive individuals is another provocative finding that warrants further study.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 28 条
[1]   Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients [J].
Balayan, MS ;
Fedorova, OE ;
Mikhailov, MI ;
Rytick, PG ;
Eremin, VF ;
Danilova, TI ;
Shevelev, BI ;
Gorbacheva, EC ;
Pankova, GY .
JOURNAL OF VIRAL HEPATITIS, 1997, 4 (04) :279-283
[2]   THE INFLUENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE DEVELOPMENT OF THE HEPATITIS-B VIRUS CARRIER STATE [J].
BODSWORTH, NJ ;
COOPER, DA ;
DONOVAN, B .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) :1138-1140
[3]   A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations [J].
Buffet, C ;
LaurentPuig, P ;
Chandot, S ;
Laurian, Y ;
Charpentier, B ;
Briantais, MJ ;
Dussaix, E .
JOURNAL OF HEPATOLOGY, 1996, 24 (01) :122-123
[4]   LOSS OF ANTIBODIES AGAINST HEPATITIS-C VIRUS IN HIV-SEROPOSITIVE INTRAVENOUS-DRUG-USERS [J].
CHAMOT, E ;
HIRSCHEL, B ;
WINTSCH, J ;
ROBERT, CF ;
GABRIEL, V ;
DEGLON, JJ ;
YERLY, S ;
PERRIN, L .
AIDS, 1990, 4 (12) :1275-1277
[5]   Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection [J].
ConryCantilena, C ;
VanRaden, M ;
Gibble, J ;
Melpolder, J ;
Shakil, AO ;
Viladomiu, L ;
Cheung, L ;
DiBisceglie, A ;
Hoofnagle, J ;
Shih, JW ;
Kaslow, R ;
Ness, P ;
Alter, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1691-1696
[6]   HETEROSEXUAL COTRANSMISSION OF HEPATITIS-C VIRUS (HCV) AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) [J].
EYSTER, ME ;
ALTER, HJ ;
ALEDORT, LM ;
QUAN, S ;
HATZAKIS, A ;
GOEDERT, JJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :764-768
[7]  
EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602
[8]  
EYSTER ME, 1994, BLOOD, V84, P1020
[9]   PREVALENCE OF HBV, HDV AND HCV HEPATITIS MARKERS IN HIV-POSITIVE PATIENTS [J].
FRANCISCI, D ;
BALDELLI, F ;
PAPILI, R ;
STAGNI, G ;
PAULUZZI, S .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1995, 11 (02) :123-126
[10]   Hepatitis E virus infection in north-east Italy: Serological study in the open population and groups at risk [J].
Gessoni, G ;
Manoni, F .
JOURNAL OF VIRAL HEPATITIS, 1996, 3 (04) :197-202